Home » HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
Generic drug company Hikma Pharmaceuticals said on Monday it planned to float on the London Stock Exchange with a price range of 265 to 330 pence, the middle of which values it at about 500 million pounds ($874.9 million).
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May